Page last updated: 2024-10-28

hydrochlorothiazide and Neonatal Alloimmune Thrombocytopenia

hydrochlorothiazide has been researched along with Neonatal Alloimmune Thrombocytopenia in 1 studies

Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
RODRIGUEZ, SU1
LEIKIN, SL1
HILLER, MC1

Other Studies

1 other study available for hydrochlorothiazide and Neonatal Alloimmune Thrombocytopenia

ArticleYear
NEONATAL THROMBOCYTOPENIA ASSOCIATED WITH ANTE-PARTUM ADMINISTRATION OF THIAZIDE DRUGS.
    The New England journal of medicine, 1964, Apr-23, Volume: 270

    Topics: Chlorothiazide; Diuretics; Female; Humans; Hydrochlorothiazide; Infant, Newborn; Infant, Newborn, Di

1964